Role of Erythropoietin In Pre-Renal Transplant Patients Undergoing Oral Surgical Procedures-Two Case Reports
Abstract
The Oral Cavity Is Often Called The "Gateway To The Body," Dentist As The "Gatekeepers Of Health." Chronic Kidney Disease Is An Emerging Disease With Increased Mortality In A Low Resource Setting, According To The Global Disease Burden Report (2015)1 Lack Of Infrastructure And Awareness Among The Public Is Diagnosed At A Late Stage, Leading To Increased Mortality. In A Parallel Line, Dentistry In Developing Countries Still Is An Alien Entity To The Rural And Suburban Areas. End-Stage Renal Failure Patients Who Were Advised For Renal Transplants Visit The Dentist With Poor Oral Hygiene And Foci Of Infection, Which Must Be Eliminated. Anemia In End Stage Renal Disease And Its Management Is Challenging For The Clinicians With The Lack Of Erythropoietin Hormone Exposes The Patients To Risk Of Fatigue, Breathlessness, Lower Quality Of Life And Blood Transfusion2, 3.From Early 1980’s Erythropoesis Stimulating Agents Were Used In Kidney Damaged Patients Undergoing Dialysis But Their Application In Oral Maxillofacial Surgery Was Scarce To Minimize Morbidity And To Avoid Blood Transfusion4-6.
Keywords: Oral Cavity, Chronic Kidney Disease, Dentistry, Oral Hygiene
Keywords:
Oral Cavity, Chronic Kidney Disease, Dentistry, Oral HygieneDOI
https://doi.org/10.22270/jddt.v13i4.5774References
Neuen Bl, Chadban Sj, Demaio Ar, Johnson Dw, Perkovic V. Chronic Kidney Disease And The Global Ncds Agenda. Bmj Glob Health 2017; 2:E000380. https://doi.org/10.1136/bmjgh-2017-000380
Thilaka Gk, Kumar Sv. A Review On Pharmacological Use Of Recombinant Human Erythropoietin In Renal And Non Renal Anemia And Other Potential Applications In Clinical Practice.Apollo Med. 2016; 13:80-85. https://doi.org/10.1016/j.apme.2016.01.004
Hörl Wh. Anaemia Management And Mortality Risk In Chronic Kidney Disease. Nat Rev Nephrol. 2013; 9:291-301. https://doi.org/10.1038/nrneph.2013.21
Ansari I, Sheikh A, Ahmed Ss, Jabbar Q, Ali S. Management Of Anemia And Other Hematologic Derangements In Patients With Chronic Kidney Disease. Arab J Nephrol, Transplant. 2014; 7:13-9.
Deicher R, Hörl Wh. Differentiating Factors Between Erythropoiesis-Stimulating Agents: A Guide To Selection For Anaemia Of Chronic Kidney Disease. Drugs. 2004; 64:499-509. https://doi.org/10.2165/00003495-200464050-00004
6 Ören B, Zengin N. The Effect Of Anemia On Quality Of Lifeand Self-Care Agency In Turkey Hemodialysis Patients. Open J Nurs. 2016; 6:443-448. https://doi.org/10.4236/ojn.2016.66046
Palmer Sc, Ruospo M, Wong G, Craig Jc, Petruzzi M, De Benedittis M, Ford P, Johnson Dw, Tonelli M, Natale P, Saglimbene V. Dental Health And Mortality In People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study. American Journal of Kidney Diseases. 2015 Oct 1; 66(4):666-76.
Pendem S, Narayana Gl, Ravi P. End Stage Renal Disease: Not A Contraindication For Minor Oral Surgery-Protocol For The Management Of Oral Surgery Patients With Esrd On Hem Dialysis. Journal of Maxillofacial And Oral Surgery. 2017 Jun 1; 16(2):231-7. https://doi.org/10.1007/s12663-016-0945-z
Abed Ts, Rasheed Ji, Fawzi Ha. Dosing Of Erythropoietin Stimulating Agents In Patients On Hemodialysis: A Single-Center Study. Indian Journal Of Public Health. 2020 Feb; 11(02):1895. https://doi.org/10.37506/v11/i2/2020/ijphrd/195110
Lundby C, Thomsen Jj, Boushel R, Koskolou M, Warberg J, Calbet Ja, Robach P. Erythropoietin Treatment Elevates Hemoglobin Concentration By Increasing Red Cell Volume And Depressing Plasma Volume. The Journal of Physiology. 2007 Jan 1; 578(1):309-14. https://doi.org/10.1113/jphysiol.2006.122689
Tang WW, Stead Ra, Goodkin Da. Effects Of Epoetin Alfa On Hemostasis In Chronic Renal Failure. American Journal Of Nephrology. 1998; 18(4):263-73 https://doi.org/10.1159/000013349
Published
Abstract Display: 534 
PDF Downloads: 583 PDF Downloads: 42 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.